Overview


Intravenous Sets Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027.
FutureWise Market Research has illustrated a report on the Intravenous Sets Market. The report provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.
The Intravenous Sets market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
B. Braun
CareFusion (Becton Dickinson)
Fresenius Kabi
Codan
Hospira
Baxter International
Vygon
Smiths Medical
ICU Medical
(Note: The list of the major players will be updated with the latest market scenario and trends)
Intravenous Sets Market
By Product Type
Primary IV Sets
Secondary IV Sets
IV Extensions Sets
By Application
Congestive Heart Failure
Crohn's Disease
Hemophilia
Immune Deficiencies
Multiple Sclerosis
By Region
North America
Europe

Asia-Pacific

Rest of the world
Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants
Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth
To provide with an exhaustive analysis on the Intravenous Sets market by product type, by application and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions
We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data From Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Intravenous Sets Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Intravenous Sets Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Intravenous Sets Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Primary IV Sets
        2. Secondary IV Sets
        3. IV Extensions Sets
  • 8.   Global Intravenous Sets Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Congestive Heart Failure
        2. Crohn's Disease
        3. Hemophilia
        4. Immune Deficiencies
        5. Multiple Sclerosis
  • 9.   North America Intravenous Sets Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           2.1. U.S.A
         2.2. Canada
        3. Market Size (USD Million) Forecast for North America 2020-2027
  • 10.   Europe Intravenous Sets Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9.Rest of Western Europe
  • 11.   Asia Pacific Intravenous Sets Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along
    • with expected regulatory needs
        1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  • 12.   Rest of the World Intravenous Sets Market Analysis 2015–2019 and Forecast
    • 2020–2027 (USD Million) along with expected regulatory needs
        1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2020-2027
  • 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •    1. B. Braun
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. CareFusion (Becton Dickinson)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fresenius Kabi
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Codan
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hospira
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Baxter International
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Vygon
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Smiths Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. ICU Medical
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
  • 14.   FutureWise SME key takeaway points for Client
Partner

Our Clients